The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Recent advances in biopolymer-based hemostatic materials
Abstract
Hemorrhage is the leading cause of trauma-related deaths, in hospital and prehospital settings. Hemostasis is a complex mechanism that involves a cascade of clotting factors and proteins that result in the formation of a strong clot. In certain surgical and emergency situations, hemostatic agents are needed to achieve faster blood coagulation to prevent the patient from experiencing a severe hemorrhagic shock. Therefore, it is critical to consider appropriate materials and designs for hemostatic agents. Many materials have been fabricated as hemostatic agents, including synthetic and naturally derived polymers. Compared to synthetic polymers, natural polymers or biopolymers, which include polysaccharides and polypeptides, have greater biocompatibility, biodegradability and processibility. Thus, in this review, we focus on biopolymer-based hemostatic agents of different forms, such as powder, particles, sponges and hydrogels. Finally, we discuss biopolymer-based hemostatic materials currently in clinical trials and offer insight into next-generation hemostats for clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The gauze’s high water absorption slows the blood flow, making it denser [14].”
From Evaluation of Chitosan-Based Axiostat as Hemostatic Dressing for Endovascular Procedures in Patients with Leriche Syndrome on Anticoagulant Therapy (2025) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silk fibroin as a functional biomaterial for tissue engineering
Sun, W., Gregory, D. A., Tomeh, M. A., & Zhao, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031499 · Cited by 552
Composite living fibers for creating tissue constructs using textile techniques
Akbari, M., Tamayol, A., Laforte, V., Annabi, N., Najafabadi, A. H., Khademhosseini, A., & Juncker, D. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201303655 · Cited by 167
Self-citationNon‐Canonical Amino Acids in Protein Polymer Design
Connor, R. E., & Tirrell, D. A. (2007) · Polymer Reviews · doi:10.1080/15583720601109552 · Cited by 103
Research works printed but not linked: 230
- Kauvar, 2006, Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations, J Trauma, 60, S3
- Donley, 2022, StatPearls
- Hu, 2018, Investigation of the effects of molecular parameters on the hemostatic properties of chitosan, Molecules, 23, 3147, 10.3390/molecules23123147 · doi:10.3390/molecules23123147
- Sung, 2021, Advances in the development of hemostatic biomaterials for medical application, Biomater Res, 25, 37, 10.1186/s40824-021-00239-1 · DOI
- Boon, 1993, An overview of hemostasis, Toxicol Pathol, 21, 170, 10.1177/019262339302100209 · doi:10.1177/019262339302100209
- Peng, 2020, Hemostatic agents for prehospital hemorrhage control: a narrative review, Mil Med Res, 7, 13
- Peng, 2010, Biomaterials for hemorrhage control, Trends Biomater Artif Organs, 24, 27
- Neuffer, 2004, Hemostatic dressings for the first responder: a review, Mil Med, 169, 716, 10.7205/MILMED.169.9.716 · DOI
- Pusateri, 2004, Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine, J Trauma, 57, 555, 10.1097/01.TA.0000136155.97758.CD · doi:10.1097/01.ta.0000136155.97758.cd
- Chiara, 2018, A systematic review on the use of topical hemostats in trauma and emergency surgery, BMC Surg, 18, 1, 10.1186/s12893-018-0398-z · DOI · Paper page
- Grissom, 2015, Topical hemostatic agents and dressings in the prehospital setting, Curr Opin Anaesthesiol, 28, 210, 10.1097/ACO.0000000000000166 · doi:10.1097/aco.0000000000000166
- Salibi, 2015, The ‘pole and tent’ pressure dressing, Emerg Med J, 32, 254, 10.1136/emermed-2014-204283 · doi:10.1136/emermed-2014-204283
- Ozer, 2010, A new method for hepatic resection and hemostasis: absorbable plaque and suture, Eurasian J Med, 42, 1, 10.5152/eajm.2010.01 · doi:10.5152/eajm.2010.01
- Vinjirayer, 2004, Securing central venous catheters: a comparison of sutures with staples, Emerg Med J, 21, 582, 10.1136/emj.2003.009860 · doi:10.1136/emj.2003.009860
- Kabiri, 2011, Preparation and characterization of absorbable hemostat crosslinked gelatin sponges for surgical applications, Curr Appl Phys, 11, 457, 10.1016/j.cap.2010.08.031 · doi:10.1016/j.cap.2010.08.031
- Khoshmohabat, 2016, Overview of agents used for emergency hemostasis, Trauma Mon, 21, 10.5812/traumamon.26023 · doi:10.5812/traumamon.26023
- Shkatula, 2020, Efficiency of different methods of temporary external hemostasis at the pre-hospital stage of emergency medical care, Новости хирургии, 28, 688
- LaPelusa, 2022, StatPearls
- Garmo, 2022, StatPearls
- Stroud, 1977, Mechanisms of zymogen activation, Annu Rev Biophys Bioeng, 6, 177, 10.1146/annurev.bb.06.060177.001141 · DOI
- Monroe, 2006, What does it take to make the perfect clot?, Arterioscler Thromb Vasc Biol, 26, 41, 10.1161/01.ATV.0000193624.28251.83 · DOI · Paper page
- Palta, 2014, Overview of the coagulation system, Indian J Anaesth, 58, 515, 10.4103/0019-5049.144643 · DOI · Paper page
- Barmore, 2022, StatPearls
- Zhong, 2021, Application and outlook of topical hemostatic materials: a narrative review, Ann Transl Med, 9, 577, 10.21037/atm-20-7160 · DOI
- Owens, 2010, Tissue factor and thrombosis: the clot starts here, Thromb Haemost, 104, 432, 10.1160/TH09-11-0771 · DOI · Paper page
- Chaudhry, 2022, StatPearls
- Kuchinka, 2021, Control of blood coagulation by hemocompatible material surfaces—a review, Bioengineering, 8, 215, 10.3390/bioengineering8120215 · DOI
- Bombeli, 2004, Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage, Br J Anaesth, 93, 275, 10.1093/bja/aeh174 · DOI
- Loof, 2014, The role of coagulation/fibrinolysis during Streptococcus pyogenes infection, Front Cell Infect Microbiol, 4, 128, 10.3389/fcimb.2014.00128 · DOI
- Wang, 2020, A natural polymer-based porous sponge with capillary-mimicking microchannels for rapid hemostasis, Acta Biomater, 114, 193, 10.1016/j.actbio.2020.07.043 · DOI
- Spotnitz, 2010, Fibrin sealant: past, present, and future: a brief review, World J Surg, 34, 632, 10.1007/s00268-009-0252-7 · DOI · Paper page
- Chan, 2015, Synthetic strategies for engineering intravenous hemostats, Bioconjug Chem, 26, 1224, 10.1021/acs.bioconjchem.5b00070 · DOI
- Blombäck, 1994, Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation, Thromb Res, 75, 521, 10.1016/0049-3848(94)90227-5 · DOI · Paper page
- Lorand, 1998, A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of γ chains by factor XIIIa, Proc Natl Acad Sci USA, 95, 537, 10.1073/pnas.95.2.537 · doi:10.1073/pnas.95.2.537
- Everse, 1998, Crystal structure of fragment double-D from human fibrin with two different bound ligands, Biochemistry, 37, 8637, 10.1021/bi9804129 · DOI · Paper page
- Soon, 2011, Modulation of fibrin matrix properties via knob: hole affinity interactions using peptide-PEG conjugates, Biomaterials, 32, 4406, 10.1016/j.biomaterials.2011.02.050 · DOI
- Stabenfeldt, 2011, A new direction for anticoagulants: inhibiting fibrin assembly with PEGylated fibrin knob mimics, Biotechnol Bioeng, 108, 2424, 10.1002/bit.23184 · doi:10.1002/bit.23184
- Chan, 2015, A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis, Sci Transl Med, 7, 277ra29, 10.1126/scitranslmed.3010383 · DOI · Paper page
- Kolodziej, 2012, Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging, Bioconjug Chem, 23, 548, 10.1021/bc200613e · doi:10.1021/bc200613e
- Kolodziej, 2014, Peptide optimization and conjugation strategies in the development of molecularly targeted magnetic resonance imaging contrast agents, Methods Mol Biol, 1088, 185, 10.1007/978-1-62703-673-3_13 · doi:10.1007/978-1-62703-673-3_13
- Brown, 2014, Ultrasoft microgels displaying emergent platelet-like behaviours, Nat Mater, 13, 1108, 10.1038/nmat4066 · DOI · Paper page
- Estevez, 2017, New concepts and mechanisms of platelet activation signaling, Physiology (Bethesda), 32, 162
- Nenna, 2021, Effect of statins on platelet activation and function: from molecular pathways to clinical effects, Biomed Res Int, 2021, 6661847, 10.1155/2021/6661847 · DOI
- Mitchell, 2021, Engineering precision nanoparticles for drug delivery, Nat Rev Drug Discov, 20, 101, 10.1038/s41573-020-0090-8 · DOI · Paper page
- Sun, 2017, Advances of blood cell-based drug delivery systems, Eur J Pharm Sci, 96, 115, 10.1016/j.ejps.2016.07.021 · DOI
- Girish, 2019, Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model, J Thromb Haemost, 17, 1632, 10.1111/jth.14552 · DOI
- Roberts, 2013, The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients, Health Technol Assess, 17, 1, 10.3310/hta17100 · DOI · Paper page
- Morrison, 2012, Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study, Arch Surg, 147, 113, 10.1001/archsurg.2011.287 · DOI · Paper page
- Brown, 2015, Design of the study of tranexamic acid during air medical prehospital transport (STAAMP) trial: addressing the knowledge gaps, Prehosp Emerg Care, 19, 79, 10.3109/10903127.2014.936635 · DOI
- Ng, 2015, Tranexamic acid: a clinical review, Anaesthesiol Intensive Ther, 47, 339, 10.5603/AIT.a2015.0011 · DOI · Paper page
- Li, 2019, Superhydrophobic hemostatic nanofiber composites for fast clotting and minimal adhesion, Nat Commun, 10, 5562, 10.1038/s41467-019-13512-8 · DOI · Paper page
- Lin, 2021, RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A, Mol Ther Nucleic Acids, 24, 658, 10.1016/j.omtn.2021.03.022 · DOI
- Wasupalli, 2018, Fundamental Biomaterials: Polymers, 37, 10.1016/B978-0-08-102194-1.00003-7 · DOI
- Jin, 2021, Polysaccharide-based biomaterials in tissue engineering: a review, Tissue Eng Part B Rev, 27, 604, 10.1089/ten.teb.2020.0208 · DOI · Paper page
- Wang, 2021, Prospects and challenges of anticancer agents’ delivery via chitosan-based drug carriers to combat breast cancer: a review, Carbohydr Polym, 268, 118192, 10.1016/j.carbpol.2021.118192 · DOI
- Tsvetkov, 2020, Synthesis of biotin-tagged chitosan oligosaccharides and assessment of their immunomodulatory activity, Front Chem, 8, 554732, 10.3389/fchem.2020.554732 · DOI
- Zehtabi, 2017, Chitosan-sodium tetradecyl sulfate hydrogel: characterization and preclinical evaluation of a novel sclerosing embolizing agent for the treatment of endoleaks, Cardiovasc Intervent Radiol, 40, 576, 10.1007/s00270-016-1557-1 · doi:10.1007/s00270-016-1557-1
- Olson, 2002, Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases, Trends Cardiovasc Med, 12, 331, 10.1016/S1050-1738(02)00183-4 · doi:10.1016/s1050-1738(02)00183-4
- Jorgensen, 2021, Advances in biocompatibility: a prerequisite for biomedical application of biopolymers, Biopolymers for Biomedical and Biotechnological Applications., 1
- Lord, 2011, The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins, Biomaterials, 32, 6655, 10.1016/j.biomaterials.2011.05.062 · DOI · Paper page
- Kalsoom Khan, 2017, Carrageenan based bionanocomposites as drug delivery tool with special emphasis on the influence of ferromagnetic nanoparticles, Oxid Med Cell Longev, 2017, 8158315, 10.1155/2017/8158315 · DOI
- Gu, 2016, Gelatin blending and sonication of chitosan nanofiber mats produce synergistic effects on hemostatic functions, Int J Biol Macromol, 82, 89, 10.1016/j.ijbiomac.2015.10.009 · doi:10.1016/j.ijbiomac.2015.10.009
- Sorlier, 2001, Relation between the degree of acetylation and the electrostatic properties of chitin and chitosan, Biomacromolecules, 2, 765, 10.1021/bm015531+ · DOI · Paper page
- Denzinger, 2016, Hemostyptic property of chitosan: opportunities and pitfalls, Biomed Mater Eng, 27, 353
- Brown, 2009, Experience with chitosan dressings in a civilian EMS system, J Emerg Med, 37, 1, 10.1016/j.jemermed.2007.05.043 · DOI · Paper page
- Granville-Chapman, 2011, Pre-hospital haemostatic dressings: a systematic review, Injury, 42, 447, 10.1016/j.injury.2010.09.037 · DOI · Paper page
- Chen, 2018, Evaluation of absorbable hemostatic agents of polyelectrolyte complexes using carboxymethyl starch and chitosan oligosaccharide both in vitro and in vivo, Biomater Sci, 6, 3332, 10.1039/C8BM00628H · DOI
- Elsabahy, 2021, Design and preclinical evaluation of chitosan/kaolin nanocomposites with enhanced hemostatic efficiency, Mar Drugs, 19, 50, 10.3390/md19020050 · doi:10.3390/md19020050
- Wu, 2020, Fabrication of chitosan@calcium alginate microspheres with porous core and compact shell, and application as a quick traumatic hemostat, Carbohydr Polym, 247, 116669, 10.1016/j.carbpol.2020.116669 · DOI
- Nishiyama, 2002, Crystal structure and hydrogen-bonding system in cellulose Iβ from synchrotron X-ray and neutron fiber diffraction, J Am Chem Soc, 124, 9074, 10.1021/ja0257319 · DOI · Paper page
- Klemm, 2005, Cellulose: fascinating biopolymer and sustainable raw material, Angew Chem Int Ed Engl, 44, 3358, 10.1002/anie.200460587 · DOI · Paper page
- Cheng, 2013, Preparation and characterization of oxidized regenerated cellulose film for hemostasis and the effect of blood on its surface, Cellulose, 20, 2547, 10.1007/s10570-013-0005-5 · DOI
- Mertaniemi, 2016, Human stem cell decorated nanocellulose threads for biomedical applications, Biomaterials, 82, 208, 10.1016/j.biomaterials.2015.12.020 · DOI
- Metaxa, 2014, Cellulose-based drug carriers for cancer therapy: cytotoxic evaluation in cancer and healthy cells, Mater Lett, 132, 432, 10.1016/j.matlet.2014.06.134 · doi:10.1016/j.matlet.2014.06.134
- Kwak, 2015, Bacterial cellulose membrane produced by Acetobacter sp. A10 for burn wound dressing applications, Carbohydr Polym, 122, 387, 10.1016/j.carbpol.2014.10.049 · DOI
- Hutchinson, 2013, Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats, Cellulose, 20, 537, 10.1007/s10570-012-9828-8 · doi:10.1007/s10570-012-9828-8
- Ohta, 2015, Development of carboxymethyl cellulose nonwoven sheet as a novel hemostatic agent, J Biosci Bioeng, 119, 718, 10.1016/j.jbiosc.2014.10.026 · doi:10.1016/j.jbiosc.2014.10.026
- He, 2014, Hemostatic, antibacterial and degradable performance of the water-soluble chitosan-coated oxidized regenerated cellulose gauze, Fibers Polym, 15, 504, 10.1007/s12221-014-0504-5 · DOI
- Karahaliloğlu, 2017, Active nano/microbilayer hemostatic agents for diabetic rat bleeding model, J Biomed Mater Res B Appl Biomater, 105, 1573, 10.1002/jbm.b.33696 · doi:10.1002/jbm.b.33696
- Fan, 2021, Morphology-controllable cellulose/chitosan sponge for deep wound hemostasis with surfactant and pore-foaming agent, Mater Sci Eng C Mater Biol Appl, 118, 111408, 10.1016/j.msec.2020.111408 · DOI
- Yan, 2017, Synthesis and properties of poly (DEX-GMA/AAc) microgel particle as a hemostatic agent, J Mater Chem B, 5, 3697, 10.1039/C7TB00768J · DOI
- Chen, 2020, Preparation and application of dextran and its derivatives as carriers, Int J Biol Macromol, 145, 827, 10.1016/j.ijbiomac.2019.11.151 · DOI
- Bhatia, 2007, Polysaccharide-based tissue adhesives for sealing corneal incisions, Curr Eye Res, 32, 1045, 10.1080/02713680701767876 · DOI
- Liu, 2019, A highly efficient, in situ wet-adhesive dextran derivative sponge for rapid hemostasis, Biomaterials, 205, 23, 10.1016/j.biomaterials.2019.03.016 · DOI · Paper page
- Artzi, 2009, Aldehyde-amine chemistry enables modulated biosealants with tissue-specific adhesion, Adv Mater, 21, 3399, 10.1002/adma.200900340 · DOI
- Artzi, 2011, Tuning adhesion failure strength for tissue-specific applications, Acta Biomater, 7, 67, 10.1016/j.actbio.2010.07.008 · DOI
- Du, 2019, Injectable hydrogel composed of hydrophobically modified chitosan/oxidized-dextran for wound healing, Mater Sci Eng C Mater Biol Appl, 104, 109930, 10.1016/j.msec.2019.109930 · DOI · Paper page
- Wang, 2012, Dextran and gelatin based photocrosslinkable tissue adhesive, Carbohydr Polym, 90, 1428, 10.1016/j.carbpol.2012.07.011 · DOI
- Liu, 2020, Efficient antibacterial dextran-montmorillonite composite sponge for rapid hemostasis with wound healing, Int J Biol Macromol, 160, 1130, 10.1016/j.ijbiomac.2020.05.140 · DOI
- Ghahramanpoor, 2011, A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects, J Mater Sci Mater Med, 22, 2365, 10.1007/s10856-011-4396-2 · DOI
- Tamayol, 2015, Hydrogel templates for rapid manufacturing of bioactive fibers and 3D constructs, Adv Healthc Mater, 4, 2146, 10.1002/adhm.201500492 · DOI
- Xie, 2022, Application of alginate-based hydrogels in hemostasis, Gels, 8, 109, 10.3390/gels8020109 · DOI
- Shi, 2016, Microspheres of carboxymethyl chitosan, sodium alginate and collagen for a novel hemostatic in vitro study, J Biomater Appl, 30, 1092, 10.1177/0885328215618354 · DOI
- Singh Chandel, 2022, Balance of antiperitoneal adhesion, hemostasis, and operability of compressed bilayer ultrapure alginate sponges, Biomater Adv, 137, 212825, 10.1016/j.bioadv.2022.212825 · DOI · Paper page
- Rong, 2015, Alginate-calcium microsphere loaded with thrombin: a new composite biomaterial for hemostatic embolization, Int J Biol Macromol, 75, 479, 10.1016/j.ijbiomac.2014.12.043 · DOI
- Zhai, 2019, Co-assembled supramolecular hydrogels of cell adhesive peptide and alginate for rapid hemostasis and efficacious wound healing, Soft Matter, 15, 8603, 10.1039/C9SM01296F · DOI
- Neuman, 2015, Hyaluronic acid and wound healing, J Pharm Pharm Sci, 18, 53, 10.18433/J3K89D · DOI
- An, 2019, A serotonin-modified hyaluronic acid hydrogel for multifunctional hemostatic adhesives inspired by a platelet coagulation mediator, Mater Horiz, 6, 1169, 10.1039/C9MH00157C · DOI
- Luo, 2019, In situ injectable hyaluronic acid/gelatin hydrogel for hemorrhage control, Mater Sci Eng C Mater Biol Appl, 98, 628, 10.1016/j.msec.2019.01.034 · DOI
- Hong, 2019, A strongly adhesive hemostatic hydrogel for the repair of arterial and heart bleeds, Nat Commun, 10, 1, 10.1038/s41467-019-10004-7 · DOI · Paper page
- Medeiros, 2021, Chondroitin sulfate from fish waste exhibits strong intracellular antioxidant potential, Braz J Med Biol Res, 54, e10730, 10.1590/1414-431x2020e10730 · DOI
- Garnjanagoonchorn, 2007, Determination of chondroitin sulfate from different sources of cartilage, Chem Eng Process Process Intensif, 46, 465, 10.1016/j.cep.2006.05.019 · doi:10.1016/j.cep.2006.05.019
- Kim, 2017, Chondroitin sulfate-based biomineralizing surface hydrogels for bone tissue engineering, ACS Appl Mater Interfaces, 9, 21639, 10.1021/acsami.7b04114 · DOI · Paper page
- Bourin, 1993, Glycosaminoglycans and the regulation of blood coagulation, Biochem J, 289(Pt 2), 313, 10.1042/bj2890313 · DOI · Paper page
- Scully, 1986, The anticoagulant properties of mast cell product, chondroitin sulphate E, Biochem Biophys Res Commun, 137, 15, 10.1016/0006-291X(86)91169-1 · doi:10.1016/0006-291x(86)91169-1
- Sharma, 2022, Chondroitin sulfate: emerging biomaterial for biopharmaceutical purpose and tissue engineering, Carbohydr Polym, 286, 119305, 10.1016/j.carbpol.2022.119305 · DOI
- Slezak, 2020, An efficacy comparison of two hemostatic agents in a porcine liver bleeding model: gelatin/thrombin flowable matrix versus collagen/thrombin powder, J Invest Surg, 33, 828, 10.1080/08941939.2019.1571130 · DOI
- Zhang, 2021, An injectable serotonin-chondroitin sulfate hydrogel for bio-inspired hemostatic adhesives with high wound healing capability, Mater Adv, 2, 5150, 10.1039/D1MA00137J · DOI
- Duncan, 2003, The dawning era of polymer therapeutics, Nat Rev Drug Discov, 2, 347, 10.1038/nrd1088 · DOI · Paper page
- González-Aramundiz, 2012, Polypeptides and polyaminoacids in drug delivery, Expert Opin Drug Deliv, 9, 183, 10.1517/17425247.2012.647906 · DOI
- Hersel, 2003, RGD modified polymers: biomaterials for stimulated cell adhesion and beyond, Biomaterials, 24, 4385, 10.1016/S0142-9612(03)00343-0 · DOI · Paper page
- Chow, 2008, Peptide-based biopolymers in biomedicine and biotechnology, Mater Sci Eng R Rep, 62, 125, 10.1016/j.mser.2008.04.004 · DOI · Paper page
- Lynn, 2004, Antigenicity and immunogenicity of collagen, J Biomed Mater Res B Appl Biomater, 71, 343, 10.1002/jbm.b.30096 · DOI · Paper page
- Takagi, 2018, Two-layer sheet of gelatin: a new topical hemostatic agent, Asian J Surg, 41, 124, 10.1016/j.asjsur.2016.09.007 · DOI
- Xie, 2021, Conjugate electrospun 3D gelatin nanofiber sponge for rapid hemostasis, Adv Healthc Mater, 10
- Li, 2020, Preparation and the hemostatic property study of porous gelatin microspheres both in vitro and in vivo, Colloids and Surf B Biointerfaces, 187, 110641, 10.1016/j.colsurfb.2019.110641 · doi:10.1016/j.colsurfb.2019.110641
- Litvinov, 2017, Fibrin mechanical properties and their structural origins, Matrix Biol, 60–61, 110, 10.1016/j.matbio.2016.08.003 · DOI · Paper page
- Feller, 2022, Why fibrin biomechanical properties matter for hemostasis and thrombosis, J Thromb Haemost, 20, 6, 10.1111/jth.15531 · DOI
- Chetter, 2017, A prospective, randomized, multicenter clinical trial on the safety and efficacy of a ready-to-use fibrin sealant as an adjunct to hemostasis during vascular surgery, Ann Vasc Surg, 45, 127, 10.1016/j.avsg.2017.06.043 · DOI
- Verra, 2018, The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial, PLoS One, 13, e0200804, 10.1371/journal.pone.0200804 · doi:10.1371/journal.pone.0200804
- Harmon, 2011, Effects of fibrin pad hemostat on the wound healing process in vivo and in vitro, Biomaterials, 32, 9594, 10.1016/j.biomaterials.2011.09.019 · doi:10.1016/j.biomaterials.2011.09.019
- Matonick, 2014, Hemostatic efficacy of EVARREST™, fibrin sealant patch vs. TachoSil® in a heparinized swine spleen incision model, J Invest Surg, 27, 360, 10.3109/08941939.2014.941444 · doi:10.3109/08941939.2014.941444
- Feroz, 2020, Keratin-based materials for biomedical applications, Bioact Mater, 5, 496, 10.1016/j.bioactmat.2020.04.007 · DOI · Paper page
- Rahmany, 2013, A mechanistic investigation of the effect of keratin-based hemostatic agents on coagulation, Biomaterials, 34, 2492, 10.1016/j.biomaterials.2012.12.008 · DOI
- Wang, 2022, Rational design of high-performance keratin-based hemostatic agents, Adv Healthc Mater, 11, e2200290, 10.1002/adhm.202200290 · DOI
- He, 2019, Human hair keratin hydrogels alleviate rebleeding after intracerebral hemorrhage in a rat model, ACS Biomater Sci Eng, 5, 1113, 10.1021/acsbiomaterials.8b01609 · DOI
- Fang, 2016, Exploration of the tight structural-mechanical relationship in mulberry and non-mulberry silkworm silks, J Mater Chem B, 4, 4337, 10.1039/C6TB01049K · DOI
- Panilaitis, 2003, Macrophage responses to silk, Biomaterials, 24, 3079, 10.1016/S0142-9612(03)00158-3 · DOI · Paper page
- Zhu, 2022, A mussel-inspired wet-adhesion hydrogel with hemostasis and local anti-inflammation for managing the development of acute wounds, Mater Des, 213, 110347, 10.1016/j.matdes.2021.110347 · DOI
- Lei, 2016, Preparation and hemostatic property of low molecular weight silk fibroin, J Biomater Sci Polym Ed, 27, 403, 10.1080/09205063.2015.1136918 · DOI
- Wei, 2020, Gellable silk fibroin-polyethylene sponge for hemostasis, Artif Cells Nanomed Biotechnol, 48, 28, 10.1080/21691401.2019.1699805 · DOI
- Shefa, 2019, Enhancement of hemostatic property of plant derived oxidized nanocellulose-silk fibroin based scaffolds by thrombin loading, Carbohydr Polym, 208, 168, 10.1016/j.carbpol.2018.12.056 · DOI
- Yang, 2018, Novel hemostatic biomolecules based on elastin-like polypeptides and the self-assembling peptide RADA-16, BMC Biotechnol, 18, 12, 10.1186/s12896-018-0422-5 · doi:10.1186/s12896-018-0422-5
- Wang, 2012, Molecular mechanisms of RADA16-1 peptide on fast stop bleeding in rat models, Int J Mol Sci, 13, 15279, 10.3390/ijms131115279 · DOI
- Wang, 2019, Design of a RADA16-based self-assembling peptide nanofiber scaffold for biomedical applications, J Biomater Sci Polym Ed, 30, 713, 10.1080/09205063.2019.1605868 · DOI
- Teng, 2021, Biomimetic glycopolypeptide hydrogels with tunable adhesion and microporous structure for fast hemostasis and highly efficient wound healing, Adv Funct Mater, 31, 2105628, 10.1002/adfm.202105628 · DOI · Paper page
- Guo, 2022, Design of functional hydrogels using smart polymer based on elastin-like polypeptides, Chem Eng J, 435, 135155, 10.1016/j.cej.2022.135155 · DOI
- Ma, 2021, Ultra-strong bio-glue from genetically engineered polypeptides, Nat Commun, 12, 3613, 10.1038/s41467-021-23117-9 · DOI · Paper page
- Lu, 2017, Mussel-inspired thermoresponsive polypeptide–pluronic copolymers for versatile surgical adhesives and hemostasis, ACS Appl Mater Interfaces, 9, 16756, 10.1021/acsami.6b16575 · DOI
- Lu, 2017, Versatile surgical adhesive and hemostatic materials: synthesis, properties, and application of thermoresponsive polypeptides, Chem Mater, 29, 5493, 10.1021/acs.chemmater.7b00255 · DOI
- Suneetha, 2019, Mussel-inspired cell/tissue-adhesive, hemostatic hydrogels for tissue engineering applications, ACS Omega, 4, 12647, 10.1021/acsomega.9b01302 · DOI
- Nie, 2013, Rapidly in situ forming chitosan/ε-polylysine hydrogels for adhesive sealants and hemostatic materials, Carbohydr Polym, 96, 342, 10.1016/j.carbpol.2013.04.008 · DOI
- Lu, 2019, Biomimetic chitosan-graft-polypeptides for improved adhesion in tissue and metal, Carbohydr Polym, 215, 20, 10.1016/j.carbpol.2019.03.065 · DOI
- Zhu, 2020, Fast and high strength soft tissue bioadhesives based on a peptide dendrimer with antimicrobial properties and hemostatic ability, ACS Appl Mater Interfaces, 12, 4241, 10.1021/acsami.9b18720 · DOI
- Xie, 2021, Conjugate electrospun 3D gelatin nanofiber sponge for rapid hemostasis, Adv Healthc Mater, 10, 2100918, 10.1002/adhm.202100918 · DOI · Paper page
- Huang, 2020, Degradable Gelatin-Based IPN cryogel hemostat for rapidly stopping deep noncompressible hemorrhage and simultaneously improving wound healing, Chem Mater, 32, 6595, 10.1021/acs.chemmater.0c02030 · DOI · Paper page
- Kheirabadi, 2008, High-pressure fibrin sealant foam: an effective hemostatic agent for treating severe parenchymal hemorrhage, J Surg Res, 144, 145, 10.1016/j.jss.2007.02.012 · doi:10.1016/j.jss.2007.02.012
- He, 2019, Human hair keratin hydrogels alleviate rebleeding after intracerebral hemorrhage in a rat model, ACS Biomater Sci Eng, 5, 1113, 10.1021/acsbiomaterials.8b01609 · DOI
- Pacheco, 2020, Use of hemostatic agents for surgical bleeding in laparoscopic partial nephrectomy: biomaterials perspective, J Biomed Mater Res, 108, 3099, 10.1002/jbm.b.34637 · doi:10.1002/jbm.b.34637
- Wang, 2020, The effect of form of carboxymethyl-chitosan dressings on biological properties in wound healing, Colloids Surf B Biointerfaces, 194, 111191, 10.1016/j.colsurfb.2020.111191 · doi:10.1016/j.colsurfb.2020.111191
- Zhang, 2020, Oxidized cellulose-based hemostatic materials, Carbohydr Polym, 230, 115585, 10.1016/j.carbpol.2019.115585 · DOI · Paper page
- Liu, 2022, Rapid hemostasis and excellent antibacterial cerium-containing mesoporous bioactive glass/chitosan composite sponge for hemostatic material, Mater Today Chem, 23, 100735, 10.1016/j.mtchem.2021.100735 · DOI
- Gutierrez, 2004, Clinical review: hemorrhagic shock, Crit Care, 8, 373, 10.1186/cc2851 · DOI
- Fülöp, 2013, Experimental models of hemorrhagic shock: a review, Eur Surg Res, 50, 57, 10.1159/000348808 · DOI
- Nichols, 2022, Recommendations for improving stop the bleed: a systematic review, Mil Med, 10.1093/milmed/usac019 · doi:10.1093/milmed/usac019
- Hong, 2006, The use of hemostatic agents and sealants in urology, J Urol, 176, 2367, 10.1016/j.juro.2006.07.128 · doi:10.1016/j.juro.2006.07.128
- di Lena, 2014, Hemostatic polymers: the concept, state of the art and perspectives, J Mater Chem B, 2, 3567, 10.1039/C3TB21739F · DOI
- Biswal, 2021, Biopolymers for tissue engineering applications: a review, Mater Today Proc, 41, 397, 10.1016/j.matpr.2020.09.628 · DOI · Paper page
- Basagaoglu Demirekin, 2015, Development of metal ion binded oxidized regenerated cellulose powder as hemostatic agent: a comparative study with in vivo performance, Ind Eng Chem Res, 54, 4906, 10.1021/ie504985b · DOI
- Bose, 2020, Additive manufacturing of natural biopolymers and composites for bone tissue engineering, Mater Horiz, 7, 2011, 10.1039/D0MH00277A · DOI
- Maleksabet, 2021, Evaluating the safety and toxicity of a modified dextran-based biopolymer as a hemostat, Curr Biotechnol, 9, 290, 10.2174/2211550109999201026090415 · DOI
- Lewis, 2014, Randomized, controlled comparison of advanced hemostatic pads in hepatic surgical models, ISRN Surg, 2014, 930803, 10.1155/2014/930803 · DOI
- Malik, 2021, Hemostatic strategies for uncontrolled bleeding: a comprehensive update, J Biomed Mater Res, 109, 1465, 10.1002/jbm.b.34806 · DOI
- Kordestani, 2012, A randomized controlled trial on the hemostasis of femoral artery using topical hemostatic agent, Clin Appl Thromb Hemost, 18, 501, 10.1177/1076029611432745 · doi:10.1177/1076029611432745
- Zheng, 2020, Research status and development potential of composite hemostatic materials, J Mater Chem B, 8, 5395, 10.1039/D0TB00906G · DOI
- Chen, 2018, Urushiol-functionalized mesoporous silica nanoparticles and their self-assembly into a Janus membrane as a highly efficient hemostatic material, Nanoscale, 10, 22818, 10.1039/C8NR05882B · DOI
- de la Harpe, 2019, The hemocompatibility of nanoparticles: a review of cell–nanoparticle interactions and hemostasis, Cells, 8, 1209, 10.3390/cells8101209 · DOI · Paper page
- Luo, 2016, Development and assessment of kerateine nanoparticles for use as a hemostatic agent, Mater Sci Eng C Mater Biol Appl, 63, 352, 10.1016/j.msec.2016.03.007 · DOI
- Yang, 2017, Design and development of polysaccharide hemostatic materials and their hemostatic mechanism, Biomater Sci, 5, 2357, 10.1039/C7BM00554G · DOI · Paper page
- Jegatheeswaran, 2012, In vivo evaluation of the chitosan-based haemostatic agent omni-stat® in porcine liver resection and in liver injury, Eur Surg Res, 49, 73, 10.1159/000337867 · DOI
- Sakoda, 2018, Injectable hemostat composed of a polyphosphate-conjugated hyaluronan hydrogel, Biomacromolecules, 19, 3280, 10.1021/acs.biomac.8b00588 · DOI
- Panwar, 2019, In-vitro and in-vivo evaluation of biocompatible and biodegradable calcium-modified carboxymethyl starch as a topical hemostat, Materialia, 7, 100373, 10.1016/j.mtla.2019.100373 · doi:10.1016/j.mtla.2019.100373
- Zhu, 2021, Hemostatic efficacy and biocompatibility evaluation of a novel absorbable porous starch hemostat, Surg Innov, 29, 367, 10.1177/15533506211046100 · doi:10.1177/15533506211046100
- Chen, 2000, Hybrid biomaterials for tissue engineering: a preparative method for PLA or PLGA–collagen hybrid sponges, Adv Mater, 12, 455, 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C · DOI · Paper page
- Rnjak-Kovacina, 2015, Lyophilized silk sponges: a versatile biomaterial platform for soft tissue engineering, ACS Biomater Sci Eng, 1, 260, 10.1021/ab500149p · DOI · Paper page
- Seol, 2004, Chitosan sponges as tissue engineering scaffolds for bone formation, Biotechnol Lett, 26, 1037, 10.1023/B:BILE.0000032962.79531.fd · DOI · Paper page
- Szymkowiak, 2021, Aligned silk sponge fabrication and perfusion culture for scalable proximal tubule tissue engineering, ACS Appl Mater Interfaces, 13, 10768, 10.1021/acsami.1c00548 · DOI
- Giannelli, 2021, Magnetic keratin/hydrotalcites sponges as potential scaffolds for tissue regeneration, Appl Clay Sci, 207, 106090, 10.1016/j.clay.2021.106090 · doi:10.1016/j.clay.2021.106090
- Zheng, 2021, A hemostatic sponge derived from skin secretion of Andrias davidianus and nanocellulose, Chem Eng J, 416, 129136, 10.1016/j.cej.2021.129136 · DOI
- Fan, 2021, Morphology-controllable cellulose/chitosan sponge for deep wound hemostasis with surfactant and pore-foaming agent, Mater Sci Eng C Mater Biol Appl, 118, 111408, 10.1016/j.msec.2020.111408 · DOI
- Wei, 2021, Polysaccharides-modified chitosan as improved and rapid hemostasis foam sponges, Carbohydr Polym, 264, 118028, 10.1016/j.carbpol.2021.118028 · doi:10.1016/j.carbpol.2021.118028
- Udayakumar, 2021, Ecofriendly biopolymers and composites: preparation and their applications in water-treatment, Biotechnol Adv, 52, 107815, 10.1016/j.biotechadv.2021.107815 · DOI · Paper page
- Li, 2022, Emerging biopolymer-based bioadhesives, Macromol Biosci, 22, 2100340, 10.1002/mabi.202100340 · DOI
- Kuo, 2016, Osteogenic differentiation of preosteoblasts on a hemostatic gelatin sponge, Sci Rep, 6, 1, 10.1038/srep32884 · DOI
- Huang, 2015, Using absorbable chitosan hemostatic sponges as a promising surgical dressing, Int J Biol Macromol, 75, 322, 10.1016/j.ijbiomac.2015.01.049 · DOI
- Wu, 2020, Antibacterial and hemostatic thiol-modified chitosan-immobilized AgNPs composite sponges, ACS Appl Mater Interfaces, 12, 20307, 10.1021/acsami.0c05430 · DOI · Paper page
- Li, 2022, Polyvinyl alcohol/sodium alginate composite sponge with 3D ordered/disordered porous structure for rapidly controlling noncompressible hemorrhage, Biomater Adv, 134, 112698, 10.1016/j.msec.2022.112698 · DOI
- Lyu, 2022, Processing-structure-properties relationships of glycerol-plasticized silk films, Molecules, 27, 1339, 10.3390/molecules27041339 · DOI
- Guo, 2020, Engineering silk materials: from natural spinning to artificial processing, Appl Phys Rev, 7, 011313, 10.1063/1.5091442 · DOI
- Li, 2020, Design of biodegradable, implantable devices towards clinical translation, Nat Rev Mater, 5, 61, 10.1038/s41578-019-0150-z · DOI · Paper page
- Guo, 2020, Thermoplastic moulding of regenerated silk, Nat Mater, 19, 102, 10.1038/s41563-019-0560-8 · DOI · Paper page
- Teuschl, 2017, Silk fibroin based carrier system for delivery of fibrinogen and thrombin as coagulant supplements, J Biomed Mater Res A, 105, 687, 10.1002/jbm.a.35940 · DOI
- Hu, 2012, Visible light crosslinkable chitosan hydrogels for tissue engineering, Acta Biomater, 8, 1730, 10.1016/j.actbio.2012.01.029 · DOI · Paper page
- Petersen, 1984, A comparison between 2 absorbable hemostatic agents: gelatin sponge (Spongostan®) and oxidized regenerated cellulose (Surgicel®), Int J Oral Maxillofac Surg, 13, 406
- Kita, 2018, Point-of-care cerebrospinal fluid detection, Otolaryngol Head Neck Surg, 159, 824, 10.1177/0194599818789075 · doi:10.1177/0194599818789075
- Lindstrom, 1956, Complications from the use of absorbable hemostatic sponges, AMA Arch Surg, 73, 133, 10.1001/archsurg.1956.01280010135018 · doi:10.1001/archsurg.1956.01280010135018
- Özer, 2017, Use of gelatin sponge affects postoperative morbidity in cesarean section patients, Med Sci Monit, 23, 1141, 10.12659/MSM.899860 · DOI
- Blaine, 1951, Absorbable gelatin sponge in experimental surgery, Lancet, 2, 427, 10.1016/S0140-6736(51)91693-5 · doi:10.1016/s0140-6736(51)91693-5
- Eastridge, 2012, Death on the battlefield (2001-2011): implications for the future of combat casualty care, J Trauma Acute Care Surg, 73, S431, 10.1097/TA.0b013e3182755dcc · DOI · Paper page
- Holcomb, 2007, Causes of death in U.S. Special operations forces in the global war on terrorism: 2001-2004, Ann Surg, 245, 986, 10.1097/01.sla.0000259433.03754.98 · DOI · Paper page
200 of 230 shown
Cited by
Perri, P., Curcio, F., De Luca, M., Piro, P., Trombino, S., & Cassano, R. (2025) · Pharmaceuticals · doi:10.3390/ph18040584 · Cited by 6
Metadata
- Authors
- Mecwan, M., Li, J., Falcone, N., Ermis, M., Torres, E., Morales, R., Hassani, A., Haghniaz, R., Mandal, K., Sharma, S., Maity, S., Zehtabi, F., Zamanian, B., Herculano, R., Akbari, M., V. John, J., & Khademhosseini, A.
- Venue
- Regenerative Biomaterials
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-01-01
- Volume
- 9
- ISSN
- 2056-3426
- Cited by
- 88
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent advances in biopolymer-based hemostatic materials. https://app.cochat.ai/papers/10.1093/rb/rbac063
- The paper
- Mecwan, M., Li, J., Falcone, N., Ermis, M., Torres, E., Morales, R., Hassani, A., Haghniaz, R., Mandal, K., Sharma, S., Maity, S., Zehtabi, F., Zamanian, B., Herculano, R., Akbari, M., V. John, J., & Khademhosseini, A. (2022). Recent advances in biopolymer-based hemostatic materials. Regenerative Biomaterials. https://doi.org/10.1093/rb/rbac063
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.